Pin‐Ji Lei

889 total citations
24 papers, 508 citations indexed

About

Pin‐Ji Lei is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Pin‐Ji Lei has authored 24 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Pin‐Ji Lei's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (5 papers). Pin‐Ji Lei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (5 papers). Pin‐Ji Lei collaborates with scholars based in United States, China and Japan. Pin‐Ji Lei's co-authors include Timothy P. Padera, Min Wu, Hengbo Zhou, Lianyun Li, Gang Wei, Xiang Wang, Lingao Ju, Quanyi Zhao, Qinglan Li and Peigen Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Pin‐Ji Lei

19 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pin‐Ji Lei United States 12 314 138 94 82 56 24 508
Justin Wang United States 9 206 0.7× 144 1.0× 122 1.3× 87 1.1× 45 0.8× 12 430
Pino Bordignon Switzerland 8 376 1.2× 217 1.6× 114 1.2× 120 1.5× 40 0.7× 12 584
Ivana Heřmanová Czechia 9 198 0.6× 97 0.7× 132 1.4× 84 1.0× 52 0.9× 16 406
Caleb A. Dawson Australia 10 265 0.8× 254 1.8× 129 1.4× 104 1.3× 48 0.9× 13 575
Jane Antony United States 10 207 0.7× 185 1.3× 165 1.8× 79 1.0× 46 0.8× 16 448
Valentina Robila United States 10 153 0.5× 129 0.9× 141 1.5× 64 0.8× 41 0.7× 25 359
Colleen Crane Canada 4 212 0.7× 116 0.8× 44 0.5× 97 1.2× 28 0.5× 5 397
Sonia Iyer United States 12 282 0.9× 121 0.9× 155 1.6× 65 0.8× 22 0.4× 23 483
Steven King United States 3 288 0.9× 116 0.8× 53 0.6× 130 1.6× 30 0.5× 8 469
Guillermo Suñé Spain 10 259 0.8× 104 0.8× 112 1.2× 33 0.4× 60 1.1× 16 413

Countries citing papers authored by Pin‐Ji Lei

Since Specialization
Citations

This map shows the geographic impact of Pin‐Ji Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin‐Ji Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin‐Ji Lei more than expected).

Fields of papers citing papers by Pin‐Ji Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pin‐Ji Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin‐Ji Lei. The network helps show where Pin‐Ji Lei may publish in the future.

Co-authorship network of co-authors of Pin‐Ji Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Pin‐Ji Lei. A scholar is included among the top collaborators of Pin‐Ji Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pin‐Ji Lei. Pin‐Ji Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabatier, Marie, Ani Solanki, Sangeetha Thangaswamy, et al.. (2025). Lymphatic collection and cell isolation from mouse models for multiomic profiling. Nature Protocols. 20(4). 884–901.
2.
Ren, Jun, Zohreh Amoozgar, Pin‐Ji Lei, et al.. (2025). Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma. Proceedings of the National Academy of Sciences. 122(4). e2319474122–e2319474122. 2 indexed citations
3.
Liu, Xin, Zelong Liu, Chengzhan Zhu, et al.. (2025). Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma. Nature Communications. 16(1). 10416–10416.
4.
Lee, Somin, Zohreh Amoozgar, Sonu Subudhi, et al.. (2025). Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma. Proceedings of the National Academy of Sciences. 122(38). e2414941122–e2414941122.
5.
Lei, Pin‐Ji, et al.. (2024). Lymphatic system regulation of anti-cancer immunity and metastasis. Frontiers in Immunology. 15. 1449291–1449291. 9 indexed citations
6.
Li, Shuang, Limeng Wu, Yanling Zhang, et al.. (2024). Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. British Journal of Cancer. 131(10). 1683–1693. 5 indexed citations
7.
Morita, Satoru, Pin‐Ji Lei, Kohei Shigeta, et al.. (2024). Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma. Cancer Immunology Research. 13(2). 162–170. 9 indexed citations
8.
Lei, Pin‐Ji, Sophia C. Kamran, Daphne A. Haas‐Kogan, et al.. (2024). A Multi-Institutional Survey of Radiation Oncology Professionals’ Knowledge, Attitudes, and Practice Behaviors Toward Sexual and Gender Minority Patients With Cancer. Advances in Radiation Oncology. 9(5). 101461–101461. 3 indexed citations
10.
Krishnan, Shanmugarajan, Somin Lee, Zohreh Amoozgar, et al.. (2024). Abstract B015: Wnt inhibition improves the efficacy of anti-PD-1 therapy in glioblastoma. Cancer Immunology Research. 12(10_Supplement). B015–B015. 1 indexed citations
11.
Liu, Xin, Tatsuya Kobayashi, Pin‐Ji Lei, et al.. (2024). 1020 Inhibiting B-cell-mediated immunosuppression to enhance the efficacy of STING agonism in hepatocellular carcinoma. Regular and Young Investigator Award Abstracts. A1141–A1141.
12.
Lei, Pin‐Ji, Ethel R. Pereira, Zohreh Amoozgar, et al.. (2023). Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes. The Journal of Experimental Medicine. 220(9). 35 indexed citations
13.
Jones, Dennis, Zixiong Wang, Ivy Chen, et al.. (2022). Solid stress impairs lymphocyte infiltration into lymph node metastases. The FASEB Journal. 36(S1). 1 indexed citations
14.
Jones, Dennis, Zixiong Wang, Ivy X. Chen, et al.. (2021). Solid stress impairs lymphocyte infiltration into lymph-node metastases. Nature Biomedical Engineering. 5(12). 1426–1436. 55 indexed citations
15.
Yao, Jie, Pin‐Ji Lei, Qinglan Li, et al.. (2020). GLIS2 promotes colorectal cancer through repressing enhancer activation. Oncogenesis. 9(5). 57–57. 22 indexed citations
16.
Li, Qinglan, Lingao Ju, Jie Yao, et al.. (2019). The hyper-activation of transcriptional enhancers in breast cancer. Clinical Epigenetics. 11(1). 48–48. 47 indexed citations
17.
Zhao, Quanyi, Pin‐Ji Lei, Xiaoran Zhang, et al.. (2016). Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model. Clinical Epigenetics. 8(1). 34–34. 64 indexed citations
18.
Ju, Lingao, Yuan Zhu, Pin‐Ji Lei, et al.. (2016). TTLL12 Inhibits the Activation of Cellular Antiviral Signaling through Interaction with VISA/MAVS. The Journal of Immunology. 198(3). 1274–1284. 21 indexed citations
19.
Li, Chunyuan, Pin‐Ji Lei, Xiang Wang, et al.. (2016). The EZH1–SUZ12 complex positively regulates the transcription of NF-κB target genes through interaction with UXT. Journal of Cell Science. 129(12). 2343–2353. 31 indexed citations
20.
Fan, Jiadong, Pin‐Ji Lei, Xiang Wang, et al.. (2015). The Selective Activation of p53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death. PLoS ONE. 10(1). e0116782–e0116782. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026